Ataraxis AI Scales Medical Foundation Model to Falcon, Expands Cancer Clinical Use
kjgeras · x · 2026-07-06
Medical AI company Ataraxis AI has upgraded its foundation model from Kestrel to Falcon (1.1 billion parameters, 2 billion patches), expanding its application scope from predicting cancer recurrence risk to assisting in evaluating chemotherapy benefits and predicting neoadjuvant therapy responses. Based on AI analysis of pathology slides, the company continues to advance clinical decision support for breast cancer, with more results to be announced soon.
More from Research
- EdgeRock open-sourced: 72 MiB KV cache at 256K context, 99.1% smaller than Qwen3.5-4B — alifcoder · 2026-10-27
- EdgeRock-4B holds KV cache at 72 MiB across 256K context, 99.1% smaller than Qwen3.5-4B — alifcoder · 2026-10-27
- TRL adds Score Centering, a simple fix for RLHF training instability — lvwerra · 2026-10-27
- Latent-Foresight: world models that learn to predict their own future — abursuc · 2026-10-27
- UK AISI papers: no good safeguards yet against misuse of biological AI tools — davidmanheim · 2026-10-27
- CMU's XYBench: LLMs answer queries literally and reinforce user misconceptions — valentina__py · 2026-10-27